Financial Statements

AbbVie Inc. (ABBV)


-1.06 (-0.76%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) 3,1271,0554,7173,368-
Net Income 11,83611,5424,6167,8825,687
Stock Dividends -136-209-562-1673,261
Dividend Paid -10,043-9,261-7,716-6,366-5,580
Retained Earnings 4,7843,1271,0554,7173,368

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 5,1105,2482,9622,883-
Annual Depreciation 5206493,0846313,521
Capital Expenditure -695-787-798-552-638
Net PPE 4,9355,1105,2482,9622,883

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -15,66315,60433,12432,379
New Purchases -1,792-583-61-119-1,438
Intangible and Goodwill 15,66315,60433,12432,37932,156

AbbVie Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AbbVie Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.